PerkinElmer and IDBS Announce Software Collaboration to Improve High Content Screening Outcomes for Drug Discovery Research

09-Jan-2009 - USA

IDBS announced a collaboration with PerkinElmer, Inc. at the 6th Annual High Content Analysis Conference in San Francisco. The collaboration will be focused on improving data analysis and interpretation of High Content Screening (HCS), an enabling technology in the search for key cellular markers associated with human health and disease.

“The future of High Content Screening lies in an increased synergy between technologies that integrate vast image content with large compound sets, to generate actionable research data,” said Richard M. Eglen, Ph.D., president, Bio-discovery, PerkinElmer. “We feel this collaboration with IDBS is a timely and highly promising advance in giving researchers access to greater insights into the cell-based mechanisms of disease, as well as development of novel therapies based on greater understanding of the origins of diseases.”

Other news from the department business & finance

Most read news

More news from our other portals

Recognise, understand, heal: The World of Diagnostics